Advertisement

Overview of IgG4-Related Kidney Disease

  • Takao SaitoEmail author
Chapter

Abstract

IgG4-related kidney disease (IgG4-RKD) is a comprehensive term for the renal lesions associated with IgG4-related disease (IgG4-RD), including IgG4-related tubulointerstitial nephritis (IgG4-related TIN), glomerular lesions, and IgG4-related pelvic lesion. The unifying disease entity of IgG4-RKD was elucidated after autoimmune pancreatitis and Mikulicz disease were recognized to occur frequently together. Involvement of multiple other organs was also identified to be part of this disease over the first dozen years of this century. A diagnostic algorithm and criteria for IgG4-RKD were proposed and published in 2011 by the IgG4-RKD working group of the Japanese Society of Nephrology. Simultaneously, another set of criteria for IgG4-related TIN was presented in the United States.

The proportion of IgG4-RKD in biopsy-proven cases is 0.67 % and its distribution does not show any regional differences in Japan. The most common histological feature of IgG4-RKD is tubulointerstitial nephritis, where the combination of IgG4-positive plasma cells and fiber bundles forms a characteristic fibrosis called “storiform” or “bird’s eye”. Glomerular lesions, most of which are membranous nephropathy, are observed in approximately 30 % of IgG4-RKD cases. In addition to the kidney parenchymal and pelvic lesions, tumefactive lesions can be located around the renal capsule and in the ureteral space and retroperitoneum. Accordingly, IgG4-RKD is closely associated with IgG4-related urological disease.

Keywords

IgG4-related disease Tubulointerstitial nephritis Storiform fibrosis Bird’s eye pattern IgG4-positive plasma cells 

Notes

Disclosure

None

References

  1. 1.
    Seshan SV, D’Agati VD, Appel GA, Churg J. Renal disease. Classification and atlas of tubule-interstitial and vascular diseases. 1st ed. Baltimore: Williams & Wilkins; 1999.Google Scholar
  2. 2.
    Seshan SV, D’Agati VD, Appel GA, Churg J, editors. Tubulo-interstitial and vascular lesions associated with immune deposits. In: Renal disease. Classification and atlas of tubule-interstitial and vascular diseases. 1st ed. Baltimore: Williams & Wilkins; 1999. p. 213–29Google Scholar
  3. 3.
    Winer RL, Cohen AH, Sawhney AS, et al. Sjögren’s syndrome with immune-complex tubulointerstitial renal disease. Clin Immunol Immunopathol. 1977;8:494–503.CrossRefPubMedGoogle Scholar
  4. 4.
    Shioji R, Furuyama T, Onodera S, et al. Sjögren’s syndrome and renal tubular acidosis. Am J Med. 1970;48:456–63.CrossRefPubMedGoogle Scholar
  5. 5.
    Aasarød K, Haga HJ, Berg KJ, et al. Renal involvement in primary Sjögren’s syndrome. QJM. 2000;93:297–304.CrossRefPubMedGoogle Scholar
  6. 6.
    Morgan WS, Castleman B. A clinicopathological study of “Mikulicz’s disease”. Am J Pathol. 1953;29:471–503.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Kambham N, Markowitz GS, Tanji N, et al. Idiopathic hypocomplementemic interstitial nephritis with extensive tubulointerstitial deposits. Am J Kidney Dis. 2001;37:388–99.CrossRefPubMedGoogle Scholar
  8. 8.
    Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Hamano H, Kawa S, Ochi Y, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Takeda S, Haratake J, Kasai T, et al. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant. 2004;19:474–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Uchiyama-Tanaka Y, Mori Y, Kimura T, et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis. 2004;43:e18–25.CrossRefPubMedGoogle Scholar
  12. 12.
    Rudmik L, Trpkov K, Nash C, et al. Autoimmune pancreatitis associated with renal lesions mimicking metastatic tumours. CMAJ. 2006;175:367–9.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Nakamura H, Wada H, Origuchi T, et al. A case of IgG4-related autoimmune disease with multiple organ involvement. Scand J Rheumatol. 2006;35:69–71.CrossRefPubMedGoogle Scholar
  14. 14.
    Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537–45.CrossRefPubMedGoogle Scholar
  15. 15.
    Shimoyama K, Ogawa N, Sawaki T, et al. A case of Mikulicz’s disease complicated with interstitial nephritis successfully treated by high-dose corticosteroid. Mod Rheumatol. 2006;16:176–82.CrossRefPubMedGoogle Scholar
  16. 16.
    Tsubata Y, Akiyama F, Oya T, et al. IgG4-related chronic tubulointerstitial nephritis without autoimmune pancreatitis and the time course of renal function. Intern Med. 2010;49:1593–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Kim F, Yamada K, Inoue D, et al. IgG4-related tubulointerstitial nephritis and hepatic inflammatory pseudotumor without hypocomplementemia. Intern Med. 2011;50:1239–44.CrossRefPubMedGoogle Scholar
  18. 18.
    Saeki T, Nishi S, Imai N, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78:1016–23.CrossRefPubMedGoogle Scholar
  19. 19.
    Cornell LD, Chicano SL, Deshpande V, et al. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol. 2007;31:1586–97.CrossRefPubMedGoogle Scholar
  20. 20.
    Yamaguchi Y, Kanetsuna Y, Honda K, et al. Characteristic tubulointerstitial nephritis in IgG4-related disease. Hum Pathol. 2012;43:536–49.CrossRefPubMedGoogle Scholar
  21. 21.
    Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15:615–26.CrossRefPubMedGoogle Scholar
  22. 22.
    Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.CrossRefPubMedGoogle Scholar
  23. 23.
    Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22:1343–52.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Deshpande V, Zen Y, Chan JKC, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.CrossRefPubMedGoogle Scholar
  26. 26.
    Nakashima H, Kawano M, Saeki T, et al. Estimation of the number of histological diagnosis for IgG4-related kidney disease referred to the data obtained from the Japan Renal Biopsy Registry (J-RBR) questionnaire and cases reported in the Japanese Society of Nephrology Meetings. Clin Exp Nephrol. 2016. doi:  10.1007/s10157-016-1260-1.
  27. 27.
    Cornell LD. IgG4-related kidney disease. Semin Diagn Pathol. 2012;21:279–88.Google Scholar
  28. 28.
    Alexander MP, Larsen CP, Gibson IW, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83:455–62.CrossRefPubMedGoogle Scholar
  29. 29.
    Tamai R, Hasegawa Y, Hisano S, et al. A case of IgG4-related tubulointerstitial nephritis concurrent with Henoch-Schönlein purpura nephritis. Allergy, Asthma Clin Immunol. 2011;7:5.CrossRefGoogle Scholar
  30. 30.
    Ito K, Yamada K, Mizushima I, et al. Henoch-Schönlein purpura nephritis in a patient with IgG4-related disease: a possible association. Clin Nephrol. 2013;79:246–52.CrossRefPubMedGoogle Scholar
  31. 31.
    Katano K, Hayatsu Y, Matsuda T, et al. Endocapillary proliferative glomerulonephritis with crescent formation and concurrent tubulointerstitial nephritis complicating retroperitoneal fibrosis with a high serum level of IgG4. Clin Nephrol. 2007;68:308–14.CrossRefPubMedGoogle Scholar
  32. 32.
    Morimoto J, Hasegawa Y, Fukushima H, et al. Membranoproliferative glomerulonephritis-like glomerular disease and concurrent tubulointerstitial nephritis complicating IgG4-related autoimmune pancreatitis. Intern Med. 2009;48:157–62.CrossRefPubMedGoogle Scholar
  33. 33.
    Saeki T, Kawano M, Mizushima I, et al. The clinical course of patients with IgG4-related kidney disease. Kidney Int. 2013;84:826–33.CrossRefPubMedGoogle Scholar
  34. 34.
    Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheum. 2015;67:1688–99.CrossRefGoogle Scholar
  35. 35.
    Kuroda N, Nakamura S, Miyazaki K, et al. Chronic sclerosing pyelitis with an increased number of IgG4-positive plasma cells. Med Mol Morphol. 2009;42:236–8.CrossRefPubMedGoogle Scholar
  36. 36.
    Saeki T, Nishi S, Ito T, et al. Renal lesions in IgG4-related systemic disease. Intern Med. 2007;46:1365–71.CrossRefPubMedGoogle Scholar
  37. 37.
    Takahashi N, Kawashima A, Fletcher JG, et al. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology. 2007;242:791–801.CrossRefPubMedGoogle Scholar
  38. 38.
    Inoue D, Kawano M, Yamada K, et al. Kidney and urinary tract lesions. In: Umehara H, Okazaki K, Stone JH, Kawa S, Kawano M, editors. IgG4-related disease. Tokyo: Springer Japan; 2014. p. 99–105.CrossRefGoogle Scholar
  39. 39.
    Watanabe R, Yasuno T, Hisano S, et al. Distinct cytokine mRNA expression pattern in immunoglobulin G4-related kidney disease associated with renal cell carcinoma. Clin Kidney J. 2014;7:269–74.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Japan 2016

Authors and Affiliations

  1. 1.Sanko ClinicFukuokaJapan
  2. 2.Faculty of MedicineFukuoka UniversityFukuokaJapan

Personalised recommendations